ONX-0914 (PR-957)
To Order Contact us: stephen@expresspharmapulse.com
ONX 0914 |
|||
| GW4334-1 | Glentham Life Sciences | 1 | EUR 98.4 |
ONX 0914 |
|||
| GW4334-25 | Glentham Life Sciences | 25 | EUR 534.9 |
ONX 0914 |
|||
| GW4334-5 | Glentham Life Sciences | 5 | EUR 198.6 |
Oprozomib (ONX-0912) |
|||
| A1934-10 | ApexBio | 10 mg | EUR 282 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-100 | ApexBio | 100 mg | EUR 895.2 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-25 | ApexBio | 25 mg | EUR 477.6 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-5 | ApexBio | 5 mg | EUR 205.2 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 255.6 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib [ONX 0912] |
|||
| GW2060-1 | Glentham Life Sciences | 1 | EUR 86.5 |
Oprozomib [ONX 0912] |
|||
| GW2060-25 | Glentham Life Sciences | 25 | EUR 428.6 |
Oprozomib [ONX 0912] |
|||
| GW2060-5 | Glentham Life Sciences | 5 | EUR 169 |
ACY-957 |
|||
| HY-104008 | MedChemExpress | 10mg | EUR 763.2 |
SMC1 (Ab-957) Antibody |
|||
| 21190-100ul | SAB | 100ul | EUR 302.4 |
SMC1 (Ab-957) Antibody |
|||
| 21190-50ul | SAB | 50ul | EUR 224.4 |
SMC1A (Ab-957) Antibody |
|||
| CSB-PA775738- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against SMC1A (Ab-957). Recognizes SMC1A (Ab-957) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
SMC1A (Ab-957) Antibody |
|||
| CSB-PA775738-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against SMC1A (Ab-957). Recognizes SMC1A (Ab-957) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
anti-SMC1 (Ab-957) |
|||
| LF-PA20461 | Abfrontier | 100 ul | EUR 400.8 |
|
Description: Rabbit polyclonal to SMC1 |
|||
PR antibody |
|||
| 10R-1954 | Fitzgerald | 100 ul | EUR 418.8 |
|
Description: Mouse monoclonal PR antibody |
|||
PR-619 |
|||
| 27714-1 | BPS Bioscience | 5 mg | EUR 220 |
|
Description: PR-619 is a non-selective, reversible inhibitor of deubiquitinases/deubiquitylases (DUBs) and ubiquitin-like isopeptidases. PR-619 inhibits many deubiquitinating enzymes in the 5-20 µM range. Additionally, PR-619 is cell permeable and treatment of cells results in the accumulation of both ubiquitin and sumo-conjugated proteins. |
|||
PR-619 |
|||
| 27714-2 | BPS Bioscience | 25 mg | EUR 535 |
|
Description: PR-619 is a non-selective, reversible inhibitor of deubiquitinases/deubiquitylases (DUBs) and ubiquitin-like isopeptidases. PR-619 inhibits many deubiquitinating enzymes in the 5-20 µM range. Additionally, PR-619 is cell permeable and treatment of cells results in the accumulation of both ubiquitin and sumo-conjugated proteins. |
|||
PR Antibody |
|||
| BF0581 | Affbiotech | 200ul | EUR 540 |
PR antibody |
|||
| 70R-13954 | Fitzgerald | 100 ug | EUR 386.4 |
|
Description: Affinity purified Rabbit polyclonal PR antibody |
|||
PR antibody |
|||
| 70R-36087 | Fitzgerald | 100 ug | EUR 392.4 |
|
Description: Rabbit polyclonal PR antibody |
|||
PR antibody |
|||
| 70R-36593 | Fitzgerald | 100 ug | EUR 392.4 |
|
Description: Rabbit polyclonal PR antibody |
|||
PR-619 |
|||
| A8212-100 | ApexBio | 100 mg | EUR 448.8 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-25 | ApexBio | 25 mg | EUR 199.2 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-5 | ApexBio | 5 mg | EUR 115.2 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 170.4 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-S | ApexBio | Evaluation Sample | EUR 97.2 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR Antibody |
|||
| F53580-0.1ML | NSJ Bioreagents | 0.1 ml | EUR 322.15 |
|
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined. |
|||
PR Antibody |
|||
| F47198-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined. |
|||
PR Antibody |
|||
| F47596-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined. |
|||
PR-619 |
|||
| HY-13814 | MedChemExpress | 50mg | EUR 439.2 |
SMC1 (Ab-957) Conjugated Antibody |
|||
| C21190 | SAB | 100ul | EUR 476.4 |
Histone H1(HH1/957) Antibody |
|||
| BNC800957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC800957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC810957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC810957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC940957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC940957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC700957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC700957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC880957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC880957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC050957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC050957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC040957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC040957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC400957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC400957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCB0957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCB0957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCAP0957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCAP0957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCA0957-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Histone H1(HH1/957), APC conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCR0957-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Histone H1(HH1/957), RPE conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCP0957-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Histone H1(HH1/957), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNUM0957-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against Histone H1(HH1/957), 1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCH0957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCH0957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNUB0957-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Concentration: 0.2mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNUB0957-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against Histone H1(HH1/957), Concentration: 0.2mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC610957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC610957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC550957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC550957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC430957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC430957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF543 conjugate, Concentration: 0.1mg/mL |
|||